However, in BRAFV600E melanoma cells, SIRT6 haploinsufficiency induced resistance of melanoma cells to mitogen-activated protein kinase (MAPK) inhibitors by activating IGF signaling (100), suggesting an anti-tumor effect of SIRT6. This evidence concerns the gene SIRT6 and neoplasm.